Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
Credit: CC0 Public Domain

A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which is published online ahead of print in JAMA Internal Medicine.

In the wake of the opioid epidemic, institutions like the American Academy of Pain Medicine (AAPM) created guidelines for monitoring on opioid medications to prevent overuse and overprescribing. According to AAPM guidelines, physicians should monitor patient's opioid use through urine drug testing at least once a year and have sign an opioid treatment agreement with them. However, previous research has found few primary care providers adhere to the guidelines because most strategies focus on changing individual prescriber behavior rather than implementing a systems-based intervention.

The TOPCARE (Transforming Opioid Prescribing in Primary Care) model brings a nurse care manager into the equation to discuss treatment plans with patients suffering from chronic pain, and to ensure monitoring occurs; provides online resources to assist prescribers, and coordinates an individualized educational session for primary care providers conducted by an expert in opioid prescribing.

"By providing team-based support for primary care providers and patients, the TOPCARE model ensures that patients are closely monitored," said Jane Liebschutz, MD, MPH, a primary care internist and addiction expert at BMC's Grayken Center for Addiction Medicine, who served as first author and co-principal investigator on the study.

In a controlled clinical trial, researchers looked at data from nearly 1,000 patients with who were treated with opioid medication in four primary care practices. Half of the patients' primary care providers received the full TOPCARE intervention and half of the primary care providers received only electronic decision support tools (mytopcare.org).

The study found that TOPCARE patients had lower opioid doses and had a 40 percent greater likelihood of having their opioid medications discontinued compared to the control patients. TOPCARE patients were also six times more likely to receive care adhering to the AAPM opioid monitoring guidelines.

"The TOPCARE model was so effective in lowering use that two of the study sites hired nurse care managers to continue the intervention and expand services to their primary care providers. Future research should look at data from state prescription drug monitoring programs and data on other substance use to get a more comprehensive view of how patients are using opioids," said Karen E Lasser, MD, MPH, a general internist at BMC with expertise in improving the quality of care for underserved patient populations, who served as co-principal investigator of the study.

Explore further: Who should treat patients with opioid use disorder?

Related Stories

Who should treat patients with opioid use disorder?

July 11, 2017
In a Point/Counterpoint, two doctors debate whether or not family physicians should provide medication-assisted treatment to their patients with opioid use disorder.

Opioid epidemic takes toll on those with chronic pain

June 30, 2017
It is not a good time to be a pain patient, says Mark Bailey, D.O., Ph.D., a pain specialist at the University of Alabama at Birmingham. It's not a good time to be a pain doctor, or a pharmacist either, he says. The nation ...

For millions on long-term opioid medications, change will be a challenge

May 26, 2016
A team of researchers at the University of Colorado School of Medicine and the VA Eastern Colorado Health Care System recently surveyed patients to understand barriers to reducing the use of opioids to manage chronic pain. ...

Patients with opioid addiction benefit from treatment initiated in ED

February 14, 2017
Patients addicted to opioids often seek care in the emergency department (ED). They are more likely to receive addiction treatment, and reduce opioid use long-term if they are started on medication to reduce cravings in the ...

Monitoring and support help patients and primary care physicians dealing with chronic pain

February 24, 2016
Within the past 10 years, the prescription of opioids for the treatment of chronic pain has increased and the abuse of opioid medications leading to addiction has been described as epidemic. Primary care practitioners (PCPs) ...

Attending physicians, residents similar in opioid Rx monitoring

April 20, 2015
(HealthDay)—Both residents and attending physicians are only partly compliant with national opioid prescribing and monitoring guidelines, according to a study published in the March issue of Pain Medicine.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.